Table 1. Demographic and Clinical Characteristicsa.
| parameters | survivor patients (702) | deceased patients (123) | P-value adjusted |
|---|---|---|---|
| demographic characteristics | |||
| age (years), median (IQR) | 73 (63–80) | 82 (78–87) | 1.15 × 10–20 |
| gender, females, n (%) | 253 (36.0%) | 58 (47.1) | 2.08 × 10–01 |
| medical history, n (%) | |||
| chronic heart failure | 29 (4.1%) | 20 (16.3%) | 1.73 × 10–06 |
| diabetes | 169 (24.1%) | 49 (39.8%) | 2.91 × 10–03 |
| hypertension | 457 (65.1%) | 88 (71.5%) | 1.00 × 10+00 |
| dyslipidemia | 240 (34.2%) | 26 (21.1%) | 7.47 × 10–02 |
| cerebrovascular disease | 42 (6.0%) | 24 (19.5%) | 3.83 × 10–06 |
| risk features | |||
| ACS classification, STEMI, n (%) | 257 (36.6%) | 26 (21.1%) | 9.41 × 10–03 |
| Killip II-III, n (%) | 101 (14.4%) | 52 (42.3%) | 2.33 × 10–12 |
| GRACE score ≥ 170, n (%) | 501 (71.4%) | 116 (94.3%) | 7.13 × 10–07 |
| NOESY RF risk score ≥ 0.454, n (%) | 197 (28.1%) | 92 (74.8%) | 1.34 × 10–22 |
a
IQR, interquartile range; ACS, acute coronary syndrome; STEMI, ST-segment elevation myocardial infarction; GRACE, Global Registry of Acute Coronary Events risk score; NOESY RF, nuclear Overhauser effect spectroscopy random forest risk score. A P value adjusted with the Bonferroni correction <0.05 is deemed significant.